Nature Communications (Aug 2022)

Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapy

  • Laura del Amo-Maestro,
  • Soraia R. Mendes,
  • Arturo Rodríguez-Banqueri,
  • Laura Garzon-Flores,
  • Marina Girbal,
  • María José Rodríguez-Lagunas,
  • Tibisay Guevara,
  • Àngels Franch,
  • Francisco J. Pérez-Cano,
  • Ulrich Eckhard,
  • F. Xavier Gomis-Rüth

DOI
https://doi.org/10.1038/s41467-022-32215-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 16

Abstract

Read online

Celiac disease is characterized by intolerance to gluten, a cereal protein. Here, the authors show that neprosin, a glutamate peptidase from the pitcher plant, efficiently cleaves gluten components under physiological conditions in vitro and in the gut of mice.